Results 111 to 120 of about 34,368 (213)

Pathology and Pathogenesis of Brain Lesions Produced by Clostridium perfringens Type D Epsilon Toxin. [PDF]

Int J Mol Sci, 2022
Finnie JW, Uzal FA.
europepmc   +1 more source

Retraction for Chen et al., "Epsilon-Toxin Production by Clostridium perfringens Type D Strain CN3718 Is Dependent upon the agr Operon but Not the VirS/VirR Two-Component Regulatory System". [PDF]

mBio, 2022
Chen J, Rood JI, McClane BA.
europepmc   +1 more source

Immobilization of Clostridium perfringens type D in calcium alginate beads: toxin production mimics free cell culture. [PDF]

Iran J Microbiol, 2022
Rakhshandeh H, Shamsaddini Bafti M, Familsatarian B, Nooshadokht M, Khazaeli P, Raiesi O, Amirheidari B.   +6 more
europepmc   +1 more source

Expression of α- and ε-toxin genes in Clostridium perfringens type D vaccine strain in contact with the Caco-2 cell line. [PDF]

Iran J Vet Res, 2022
Forouzan AR, Moori Bakhtiari N, Seify Abad Shapouri MR, Salabi F, Khosravi M.   +4 more
europepmc   +1 more source

Peptides for toxinogenesis of Clostridium perfringens type D [PDF]

Journal of Bacteriology, 1965
openaire   +2 more sources

Chemotactic factor inducing Interleukin-8 (IL8) gene is transcriptionally elevated in experimental enterotoxaemia in goats caused by Clostridium perfringens type D. [PDF]

Heliyon, 2021
Gangwar NK, Pawaiya RVS, Gururaj K, Singh DD, Andani D, Kumar A, Sharma DK, Rao AR, Rai A.   +8 more
europepmc   +1 more source

Haemorrhagic enteritis in newborn calves associated with Clostridium perfringens and colostrum delivery [PDF]

, 2015
Deprez, Piet, Ducatelle, Richard, Goossens, Evy, Haesebrouck, Freddy, Pardon, Bart, Timbermont, Leen, Valgaeren, Bonnie, Van Immerseel, Filip, Verherstraeten, Stefanie   +8 more
core   +1 more source

In vitro potency test for evaluation of Clostridium perfringens type D epsilon toxoid

Arquivos do Instituto Biológico
The control of enterotoxemia caused by the epsilon toxin, produced by Clostridium perfringenstype D, is based on vaccination with epsilon toxoid. The potency test for this immunogen is conducted using seroneutralization in mice.
Felipe Masiero Salvarini, Zélia Ines Portela Lobato, Prhiscylla Sadanã Pires, Rodrigo Otávio Silveira Silva, Guilherme Guerra Alves, Pedro Lúcio Lithg Pereira, Francisco Carlos Faria Lobato   +6 more
doaj   +1 more source

Immunogenicity assessment of Clostridium perfringens type D epsilon toxin epitope-based chimeric construct in mice and rabbit. [PDF]

3 Biotech, 2020
Singh AP, Prabhu SN, Nagaleekar VK, Dangi SK, Prakash C, Singh VP.   +5 more
europepmc   +1 more source

Development and Evaluation of Clostridium perfringens Type D Toxoid Vaccines [PDF]

Pakistan Journal of Zoology, 2018
Mumtaz Ali Khan, Aneela Zameer Durrani, Sher Bahadar Khan, Shehla Gul Bokhari, Ikramul Haq, Imdad Ullah Khan, Naimat Ullah, Naimat Ullah Khan, Kashif Hussain, Azmat Ullah Khan   +9 more
openaire   +1 more source